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Highlights 
 
-  Expression of SOD1G93A in Drosophila thoracic muscles causes FALS phenotype. 
-  24B-GAL4-SOD1G93A flies show impaired motor behavior and decreased lifespan. 
-  24B-GAL4-SOD1G93A flies successful mimic mitochondrial dysfunction in FALS. 
-  24B-GAL4-SOD1G93A represents novel therapeutic opportunities in FALS. 
 
 
 
Abstract 
Mitochondrial pathology is a basic pathological hallmark of familial amyotrophic lateral 
sclerosis (FALS) extensively manifested by human patients and mutant SOD1G93A 
mammalian models. Rodents expressing human FALS-associated mutations 
successfully mimic several human disease features although they are not as amenable to 
genetic and therapeutic compound screenings as non-mammalian models.  In this study 
we report a newly generated and characterized Drosophila model that expresses human 
SOD1G93A in muscle fibers. Presence of SOD1G93A in thoracic muscles causes 
mitochondrial pathology and impairs normal motor behavior in these flies. Use of this 
new FALS-24B-SOD1G93A fly model holds promise to provide further understanding of 
the mitochondrial affectation process and new discoveries of therapeutic compounds 
able to reverse mitochondrial dysfunction in FALS. 
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Introduction 
Amyotrophic lateral sclerosis (ALS) is a devastating motor neuron disease that involves 
the progressive loss of motor neurons leading to paralysis and death. Although the 
etiology of ALS remains unclear, mitochondrial pathology has been found even at pre-
symptomatic stages of ALS and is currently considered a converging point of multiple 
pathological pathways in that disease (Shi et al., 2010). From the apparition of familial 
amyotrophic lateral sclerosis (FALS) human SOD1 mutants in 1993 (Rosen et al., 1993) 
research in ALS has been almost exclusively conducted in FALS rodent models. The 
advantages regarding the use of these animals have been properly and extensively 
justified although its use dramatically limits the possibilities to perform extensive 
primary therapeutic compounds screenings in ALS. Prohibitive economic and ethical 
costs together with discouraging time periods prior to the manifestation of disease 
hallmarks are the classical disadvantages of rodents for that purpose (Lee et al., 2014).  
On the contrary, the fly Drosophila melanogaster fulfils the empty space between in 
vitro models and mammal models for primary drug screenings in neurodegenerative 
diseases (Tickoo and Russell, 2002, Imai et al., 2012). Use of Drosophila implies 
extremely low costs of maintenance and handling, fast development of disease 
hallmarks and the possibility to test different forms of administration and toxic effects 
of promising therapeutic compounds (Matthews et al., 2005, Pandey and Nichols, 
2011).  
In this study we report a new fly model of ALS expressing the human FALS mutant 
SOD1G93A under the 24B-Gal4 muscle-specific promoter. Expression of SOD1G93A in 
thoracic muscles, the region of flies that contains higher presence of mitochondria and 
higher energetic expenses, shortens lifespan, impairs motor behavior and causes 
mitochondria dysfunctions in these animals. Characterization of SOD1G93A-24B-Gal4 
flies opens new venues for genetic and extensive primary drug screenings aimed to treat 
FALS-associated mitochondrial pathology 
 
Material and Methods 
 
Fly stocks 
Gal4/Uas system was used for expression of our transgenes in Drosophila flies as 
previously described (Duffy, 2002).The fly line 24B-Gal4 used in our experiments was 
obtained from the Bloomington Stock Center (IN., U.S.A.). Flag-tagged wild-type 
human SOD1 and human FALS-associated mutant SOD1G93A cDNAs were cloned into 
pUAST expression vectors. Sequencing of cloned products was performed and pUAST 
generated plasmids were sent to BestGene (CA., U.S.A.) for microinjection. Eight lines 
of each transgene were generated and at least two transgenic fly lines of each mentioned 
transgene (male) were used in our experiments. 
Immunohistochemistry and western blotting  
All antibodies and reagents were purchased from Sigma Aldrich (MO, USA) unless 
specified otherwise. AJ10 antibody was kindly provided by Esquerda and colleagues. 
Flies were submerged in a fixative solution (4% PFA in 1x PBS) overnight at 4 °C. 
Tissues were then cryoprotected and frozen at -80 °C in cryogenic solution buffer as 
previously described by (Gallart-Palau et al., 2014). Cryostat sectioning at 14 µm was 
performed (LEICA, Germany) and tissue sections were mounted in gelatinized slides. 
Immunohistochemistry protocol was followed as previously described by (Gallart-Palau 
et al., 2014).  Mouse anti-flag (1:300), rabbit AJ10 (1:250) and anti-mouse Alexa-488 
and anti-rabbit Alexa-594 (1:500) were used as primary and secondary antibodies 
respectively. Slides were mounted with a drop of Vectashield mounting media 
(Vectorlabs CA, USA) prior to the image acquiring in the confocal microscope 
Fluoview FV-1000 (Olympus, Germany).  
Western blotting of flies transgene expression was done in denaturant conditions as 
previously reported (Gallart-Palau et al., 2015) and 24B-GAL4/+ lines were used as 
negative controls. Briefly, SOD1WT and SOD1G93A independent pools were formed by a 
total of 10 flies including 5 flies from each respective line of 24B-GAL4/+, hSOD1WT 
and hSOD1G93A respectively. Whole flies were homogenized in 1% SDS and proteins 
were resolved in a SDS-PAGE gel. Mouse anti-flag-HRP (1:1000) and mouse--tubulin 
(1:1000) were incubated on blotted nitrocellulose membranes as primary antibodies. 
Anti-mouse-HRP (1:500) was incubated as secondary antibody.  
Transmission electron microscopy of thoracic muscles 
Preparation of thoracic muscles was performed as previously described by our group 
(Wang et al., 2007). Briefly, 15d-old flies were deeply anesthetized with CO2 and their 
thoraces were dissected under binocular loupe. Muscle tissues were extracted, 
submerged overnight into a fixative solution (2.5% glutaraldehyde in 0.1 M phosphate 
buffer, pH 7.2) and postfixed in 1% OsO4 for 1 h. Tissues were next dehydrated in 
ethanol series and embedded in Spurr's resin. Ultrathin sections were stained with 
uranyl acetate and lead citrate prior to be observed under a JEM-1230 electron 
microscope (Jeol, Peabody, MA). 
Survival and climbing assays 
Male flies were transferred to new food vials every 2-3 days and scored for death. Food 
vials containing non-yeasted standard food housed a maximum of 20 individuals. A 
total of 25 individuals per line expressing human wild-type and G93A SOD1 and 24B-
GAL4/+ transgenes were CO2 anesthetized and placed into vertical plastic columns of 
15cm length and 1.5 cm diameter for climbing assays. One hour was given to each 
group for recovery purposes and then they were gently tapped to the bottom of the 
column and the number of individuals that reached the top at 1 min was scored. 
Climbing assays were performed in triplicate for each line in intervals of 15 minutes.  
Image analysis and statistical analyses  
Confocal microscope images were obtained using a Fluoview FV-500 (Olympus, 
Hamburg, Germany). Scanning parameters were kept constant during the aquisition of 
all images. Images were analyzed using fluoview software (Olympus, Hamburg, 
Germany) and imageJ (NIH, MD., USA)(Schneider et al., 2012) and antibody spots 
were manually counted. Only clearly visible and round shaped spots were quantified. 
Quantitative data between 24B-GAL4/+, hSOD1WT and hSOD1G93A fly lines was 
compared by one-way analysis of variance. Kaplan-Meier analysis was performed and 
survival log rank trends were analyzed by Chi-square. Level of significance in all 
anlyses was established at p <0.05 unless specified otherwise. 
 
Results and Discussion 
 
hSOD1G93A expression in Drosophila thoracic muscles 
Mass distribution of muscle fibers in Drosophila is highly prominent in thoracic regions 
to sustain the dynamism of legs and wings (Deak, 1977). A clear advantage of the UAS-
GAL4 system is the selective spatial expression of transgenes in specific cells, tissues 
and body regions (Matthews et al., 2005). We analyzed the expression of human 
SOD1WT and hSOD1G93A under the 24B promoter and found that was more than 80 
percent of hSOD1 expression was confined to thoracic muscle fibers in all transgenic 
flies (Figure 1A and 1B).  
Exclusive expression of hSOD1G93A in skeletal muscles of transgenic mice was initially 
performed by Dobrowolny and colleagues (Dobrowolny et al., 2008). The authors found 
that this FALS mutant restrictively expressed in skeletal muscles causes reduction of the 
metabolic activity of muscle fibers, atrophy and sarcolemma in muscle tissues and 
finally higher accumulation of ROS. Later, restricted expression of FALS mutant 
SOD1G93A in skeletal muscles promoted motoneuron degeneration via retrograde 
degeneration of motoneuron axons (Wong and Martin, 2010). These studies suggest that 
affectation of SOD1G93A in muscle fibers is a crucial event in the triggering of 
neuropathology in FALS; what justifies the investigation of the effects of SOD1G93A 
mutant following muscle-restricted expression in a novel Drosophila FALS model. 
Flies expressing neurodegenerative disease-associated mutants under the 24B-GAL4 
promoter, a muscle tissue specific driver, have been previously used to study 
mitochondrial dysfunctions in Parkinson´s Disease (PD) by our group (Ng et al., 2012).  
We believed that expression of human SOD1G93A in muscles would cause ALS-
associated mitochondrial pathology in Drosophila flies. To further confirm expression 
of SOD1 in our transgenic Drosophila lines we analyzed hSOD1WT and hSOD1G93A 
expression levels by anti-flag antibody image quantification and no significant 
differences were found on the expression of transgenes between these two lines (Figure 
2H). Additionally, hSOD1 expression in transgenic lines was validated by WB (Figure 
2I). 
Toxic isoforms of misfolded SOD1 in thoracic fibers of hSOD1G93A flies 
Toxicity of hSOD1G93A is associated with the apparition of misfolded isoforms of the 
protein that can be identified by specific antibodies (Pickles and Vande Velde, 2012). 
One of these antibodies is AJ10 which was characterized by Sabado and colleagues as 
able to bind to misfolded and toxic isoforms of hSOD1 (Sábado et al., 2013). We used 
AJ10 antibody to identify misfolded and toxic isoforms of hSOD1 in our transgenic 
flies. Positive colocalization (57.6%) (Figure 2G) was evidenced in thoracic tissues of 
hSOD1G93A flies whereas no positive staining was found in hSOD1WT control flies 
(Figure 2A-F). 
Expression of hSOD1G93A in thoracic muscles causes mitochondrial pathology  
Between the 30 - 40% of our 24B-GAL4-SOD1G93A flies shown an unforeseen upheld 
wing phenotype unobserved in the 24B-hSOD1WT flies (Figure 3A). A very close 
phenotype to our findings was previously reported by Deak and colleagues (Deak, 
1977) during analysis of upheld mutant flies. According to these authors those mutants 
held-up their wings vertically and stacked, were flightless and unable to jump as we 
observed only in our upheld hSOD1G93A flies. Deak and colleagues also observed 
abnormalities on the legs and cuticle density of upheld mutant flies and these defects 
were not apparently resembled by our model. Deak and colleagues also found that 
upheld mutants displayed dramatic disorganization of indirect flight muscles including 
extreme loss of fibers and abnormal mitochondria distribution whereas no specific 
mitochondria pathology was reported in those mutants by histological analyses (Deak, 
1977).  Although muscle disorganization can cause abnormal wings posture in flies 
(upheld or flapwing) as referred by Deak, recently, singular alterations in normal 
mitochondrial dynamics caused by neurodegenerative mutants have been associated to 
apparition of abnormal wing phenotype without affectation of muscle fibers what could 
help to explain our hSOD1G93A encountered phenotype (Deng et al., 2008, Ng et al., 
2012, Rai et al., 2014). 
 
It has been shown that toxic and misfolded isoforms of hSOD1 as those identified in our 
hSOD1G93A flies affect preferentially the mitochondria in FALS models (Pickles and 
Vande Velde, 2012). In order to characterize the tissues expressing ALS-SOD1G93A in 
upheld phenotypic flies and hSOD1WT in control flies, thoracic ultrastructural analyses 
by transmission electronic microscopy (TEM) were performed. ALS-SOD1G93A TEM 
images showed, in general terms, normal organization of muscle fibers as it was also 
observed in controls (Figure 3B-D). However, a clear pattern of mitochondrial 
affectation was observed in ALS fly mutants in concordance to what was previously 
reported in ALS-SOD1G93A rodent models (Vande Velde et al., 2011, Pickles et al., 
2013, Song et al., 2013). Mitochondria in 24B-SOD1G93A flies exhibit abnormal inner 
structures including cristae, what clearly suggests impairment of the cellular organelle 
membranes. In addition, elongate mitochondria were often observed together with 
rounded and swollen organelle profiles (Figure 3C and 2D; swollen mitochondria 
indicated by an asterisk). None of these ALS pathological hallmarks were seen in 
hSOD1WT flies (Figure 3B). In the same light, presence of autophagosome-like features 
were also observed in 24B-GAL4-SOD1G93A flies mitochondria (Figure 3D; dark 
blue arrow). Disorganized and impaired mitochondria as we identified in our ALS 
mutant flies is related with depletion of energy in thoracic muscle fibers what promotes 
apparition of the identified upheld phenotype (Ng et al. 2012). 
SOD1G93A impairs Drosophila motor behavior and shortens lifespan  
Upheld wings phenotype arose around 7-10 postnatal days in 24B-hSOD1G93A and 
rendered only the affected flies as flightless. Impaired climbing ability was clearly 
manifested in one of the analyzed 24B-hSOD1G93A lines at 15 day post-eclosion, 
whereas in the other 24B-hSOD1G93A line the impaired climbing ability was evidenced 
around five days later in all cases compared to 24B-hSOD1WT control flies (Figure 4A). 
Climbing ability of upheld wing 24B-hSOD1G93A flies was highly similar to non-upheld 
wing flies in the same lines. Additionally, survival studies showed decline in survival 
for the ALS-mutant flies after 25 days post-eclosion compared to controls although the 
survival decline was especially apparent in the upheld wing flies (Figure 4B). Despite 
that significant differences on the expression level of transgenes between transgenic 
lines were not identified in our study, higher in-line variation as it has been recently 
described (Huang et al., 2015) may explain some encountered behavioral discrepancies 
between same transgene lines in our study.  
Behavioral assays as climbing and survival assays reflect disease phenotypes in several 
neurodegenerative transgenic fly models. As has been shown by our 24B-SOD1G93A 
flies characterized here, the mitochondrial affectation has also been mainly manifested 
by abnormal wings posture and impaired climbing abilities in PD transgenic models 
(Ng et al., 2012). Impaired motor ability was observed near the terminal stage of FALS 
flies, what would be in close accordance to hSOD1G93A mammal models (Gallart-Palau 
et al., 2014). 
 
 
 
 
 
 
Conclusions 
We demonstrate here that overexpression of hSOD1G93A in Drosophila muscle fibers 
causes a characteristic pathogenic phenotype that includes flightless upheld wings, 
climbing defects and mitochondrial dysfunction; features that resemble human FALS. 
Due to the easy handling, simple genetic modification and highly “druggable” capacity, 
we believe that the new hSOD1G93A Drosophila FALS model reported here will provide 
significant opportunities to study and rescue the pathogenic interactions between SOD1 
mutants and mitochondria in ALS. 
The authors declare no conflict of interest regarding to this report. 
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Figure captions 
Figure 1. Spatial expression of hSOD1 in Drosophila flies. Immunohistochemistry 
experiments were performed to confirm the spatial expression of FALS transgenes 
(hSOD1G93A and hSOD1WT) in our newly generated transgenic Drosophila lines. A. 
Image panel showing Dapi staining, hSOD1 anti-flag staining and the merged image in 
thoracic and abdominal regions of Drosophila body. Scale bar represents 850 µm. B. 
Quantification of hSOD1 expression in thoracic and abdominal regions of Drosophila 
body in our transgenic lines. As shown in the graph thoracic expression of hSOD1 was 
significantly higher (p<0.001) than abdominal expression under the 24B promoter. 
 
Figure 2. Analysis of hSOD1 expression in Drosophila transgenic lines. A. Confocal 
image showing anti-flag hSOD1 antibody signal in thoracic tissues of hSOD1WT 
transgenic flies. B. Confocal image showing anti-AJ10 antibody signal in thoracic 
tissues of hSOD1WT transgenic flies. C. Confocal image showing the merged image of 
anti-flag and AJ10 signal in thoracic tissues of hSOD1WT transgenic flies. Merged 
image shows absence of colocalization between both antibodies in WT transgenic flies. 
D. Confocal image showing anti-flag antibody signal in thoracic tissues of hSOD1G93A 
transgenic flies. E. Confocal image showing anti-AJ10 antibody signal in thoracic 
tissues of hSOD1G93A transgenic flies. F. Confocal image showing the merged image of 
anti-flag and AJ10 signal in thoracic tissues of hSOD1G93A transgenic flies. Merged 
image shows colocalization (yellow spots) between both antibodies in G93A transgenic 
flies. Scale bar represents 500 µm. G. Percentage quantification of colocalized 
hSOD1G93A and misfolded and toxic isoforms of hSOD1 stained by AJ10 antibody. H. 
SOD1 expression in WT and G93A flies was quantified and no significant differences 
were found on the expression pattern of these transgenes. I. hSOD1 expression was 
validated by WB. 
 
Figure 3. Characterization of the newly generated FALS-24B-hSOD1G93A Drosophila 
lines. A. Image showing the upheld phenotype caused by expression of hSOD1G93A in 
thoracic muscles of Drosophila flies. Expression of hSOD1WT in Drosophila thoracic 
muscles does not cause any apparent phenotype. B. Ultrastructural image showing the 
thoracic muscular fibers and mitochondria of Drosophila flies following expression of 
hSOD1WT. C. Ultrastructural image of Drosophila thoracic muscles following 
expression of the FALS mutant of hSOD1G93A, mitochondria show clear dynamic 
dysfunction (pro-fusion pattern) and the inner structures are visible showing damage on 
the mitochondria outer and intermediate membranes. D. Ultrastructural image of 
Drosophila thoracic muscles were swollen mitochondria (pointed by *) and 
autophagosome-like structures (pointed by blue arrow) are apparent following 
expression of hSOD1G93A in Drosophila flies. Scale bar in B,C and D ultrastructural 
images represents 2µm. 
 
Figure 4. Behavioral characterization of FALS-24B-hSOD1G93A Drosophila lines. A. 
Trend line graph showing the climbing assay performance of Drosophila lines. 24B-
GAL4/+, hSOD1WT and hSOD1G93A fly lines were analyzed and climbing defects were 
apparent hSOD1G93A transgenic flies from day 10 post-eclosion onwards. Significance 
level * p<0.05. B. Kaplan-Meier analysis of survival was performed in 24B-GAL4/+, 
hSOD1WT and hSOD1G93A fly lines. Significant survival declination peak was found at 
day 25 post-eclosion. Chi-square log rank trend analysis 13.85, p-value<0.001. 
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